(231f) Controlling Polymorphism and Orientation of Nu-901/Nu-1000 Metal–Organic Framework Thin Films | AIChE

(231f) Controlling Polymorphism and Orientation of Nu-901/Nu-1000 Metal–Organic Framework Thin Films

Authors 

Verma, P. - Presenter, University of Virginia
Huelsenbeck, L., University of Virginia
Nichols, A., University of Virginia
Islamoglu, T., Northwestern University
Heinrich, H., University of Virginia
Machan, C., University of Virginia
Giri, G., University of Virginia
NU-1000, a zirconium (Zr)-based metal–organic framework (MOF), is a promising candidate for heterogeneous catalysis, gas storage, electrocatalysis, and drug-delivery applications due to its large pore size and mesoporous structure. However, the synthesis of NU-1000 may produce another polymorph NU-901, which has a smaller average pore size and pore volume than NU-1000. Similarly, the presence of NU-1000 as a phase impurity in NU-901 crystallites is undesired. Although phase-pure NU-901 and NU-1000 have been successfully synthesized in bulk, multiple applications such as electrocatalysis and separation membranes require the formation of thin films. In this study, we utilize self-assembled monolayers and crystal engineering to control the polymorphism and orientation of NU-901/NU-1000 thin films. We report the fabrication of thin films of NU-901 and NU-1000 via a solvothermal method by functionalizing the substrate with carboxyl (−COOH) tail groups. This synthesis produces phase-pure hexagonal rod-shaped NU-1000 crystals and nearly phase-pure prolate-shaped NU-901 crystal as revealed by scanning electron microscope (SEM), powder X-ray diffraction (PXRD), and nitrogen adsorption isotherm analyses. Furthermore, we control the orientation of NU-1000 crystallites on the fluorine-doped tin oxide (FTO) substrate by controlling the nucleation density of the MOFs on the substrate. We hypothesize that heating the functionalized substrate in a Zr-oxo cluster solution preceding solvothermal synthesis results in the coordination of Zr-oxo clusters to the (−COOH) groups of the substrate, which promotes a higher nucleation density of NU-1000 on the substrate, resulting in the perpendicular growth of NU-1000 during crystal formation. The method developed to alter the orientation of NU-1000 may pave the way for controlling the orientation of other anisotropic MOFs, which has implications in catalysis, separation, and drug delivery.